Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously

NCT02805010 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
22
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.

Collaborators